Recent developments include quarterly financial results, strategic divestitures, financing agreements, and partnerships enhancing the company's IPO consulting services.

• HeartCore Enterprises reported a Q3 2025 loss but revenue exceeded expectations [N1].
• The company posted a profit in fiscal Q2 2025 and beat revenue estimates [N7][N8].
• In July 2025, HeartCore secured a $27 million financing agreement to support M&A strategy and software growth initiatives [N7].
• HeartCore partnered with Silver Egg Technology to integrate an AI-driven recommendation engine into its CMS platform in June 2025 [N7].
• The company signed a consulting agreement with tmsuk Co. Ltd. for IPO services in June 2025 [N7].
• On June 22, 2026, HeartCore completed the sale of its 51% interest in Sigmaways, receiving upfront and contingent earn-out payments [S2].
• The company faces Nasdaq minimum bid price compliance challenges with extended deadlines granted through May 2026 [S1].

The company has demonstrated the ability to secure consulting agreements with multiple Japanese companies pursuing U.S. IPOs, supported by a comprehensive service offering tailored to the unique regulatory and cultural challenges of cross-border listings. Recent financing arrangements and partnerships to integrate AI-driven technologies indicate efforts to enhance service capabilities. The divestiture of non-core software assets allows focused resource allocation on the GO IPO consulting business, potentially improving operational efficiency and client service quality [N1][N7][N8].

HeartCore faces significant competitive risks from larger, more established global consulting and financial advisory firms with greater resources and client relationships. Revenue concentration among a small number of clients following divestitures increases financial volatility and credit risk. The company also confronts Nasdaq listing compliance challenges related to minimum bid price requirements, which could impact its market presence. The uncertain realization of earn-out payments from Sigmaways divestiture adds financial uncertainty [S2].

HeartCore's competitive moat is based on its niche specialization in facilitating Japan-to-U.S. IPO transitions, combining technical accounting expertise, process mining technology, bilingual execution, and investor communications into an integrated service suite. Its aligned compensation model accepting warrants aligns interests with client success, and its independent advisory role avoids conflicts of interest common in integrated financial institutions. These factors differentiate it from larger global consultancies and investment banks, although the market remains competitive and fragmented with firms possessing greater resources and established relationships.

• Customer Concentration Risk: Following the sale of Sigmaways, revenue and accounts receivable are concentrated among a smaller number of key customers, increasing volatility and credit risk from potential non-payment or reduced business from these clients [S2].
• Competitive Pressure: The company competes with larger global consulting firms and investment banks that have more extensive resources, longer operating histories, and established relationships, which may pressure pricing and market share [S1].
• Nasdaq Listing Compliance Risk: The company received a notice for non-compliance with Nasdaq's minimum bid price requirement and has been granted extended periods to regain compliance. Failure to do so could result in delisting [S1].
• Earn-out Uncertainty: The earn-out consideration from the Sigmaways divestiture is contingent on future revenue thresholds and may not be realized, adding financial uncertainty [S2].

• HeartCore Enterprises, Inc. is a Delaware corporation incorporated on May 18, 2021, with consolidated subsidiaries including HeartCore Financial, Higgs Field Co., Ltd. in Japan, HeartCore Luvina Vietnam Company Limited, and Sigmaways, Inc. and its subsidiaries [S1].
• The company transitioned from a software development business to focus exclusively on its GO IPO consulting business starting in 2025, selling its software business assets in Japan including HeartCore Japan and assessing divestiture of its 51% interest in Sigmaways [S1].
• The GO IPO consulting business supports Japanese companies seeking IPOs and listings on U.S. exchanges such as Nasdaq and NYSE, providing services including introductions to law firms, underwriters, auditors, process mining licenses, internal control documentation, accounting data conversion from Japanese GAAP to U.S. GAAP, S-1 or F-1 filing assistance, English translation, investor presentations, and listing support [S1].
• The company does not provide investment advice, legal or accounting advice, or act as an underwriter or broker-dealer, maintaining an independent advisory role [S1].
• Compensation for consulting services includes cash fees and warrants or stock acquisition rights representing 1% to 4% of the fully diluted share capital of client companies [S1].
• Sales and marketing focus on growth-stage Japanese enterprises seeking U.S. capital markets access, leveraging strategic partnerships with securities firms, legal advisors, accounting firms, and financial consultants, as well as referrals and direct outreach [S1].
• The company competes in a fragmented market with global consulting firms, specialized financial advisory firms, and investment banks' advisory arms [S1].
• Competitive advantages include niche specialization in Japan-to-U.S. IPO consulting, integrated execution combining technical accounting, process mining, translation, and investor deck preparation, an aligned compensation model accepting warrants, and independence from auditors and underwriters [S1].
• The company faces competitive risks from larger firms with greater resources and established relationships, which could pressure pricing and market share [S1].
• Recent strategic developments include establishment of Higgs Field Co., Ltd. in Japan to provide consulting on digital securities and plans to pursue securities firm registration in Japan [S1].
• The company completed the sale of its entire 51% interest in Sigmaways and its subsidiaries on June 22, 2026, receiving $1,000 upfront and potential earn-out up to $649,000 based on Sigmaways' gross revenue thresholds over 12 months; post-sale, the company no longer consolidates Sigmaways' operations [S2].
• Following the Sigmaways divestiture, revenue is concentrated among a smaller number of key customers, increasing revenue and cash flow volatility and credit risk from accounts receivable concentration [S2].
• Financial snapshot as of June 30, 2026: cash and equivalents $587,074; short-term investments $2,668,317; current assets $4,264,141; current liabilities $3,660,101; current ratio 1.17; cash ratio 0.89 [S2].
• For the six months ended June 30, 2025, revenue was $4,744,246 [S2].
• For the six months ended June 30, 2026, net loss was $2,023,080; basic and diluted EPS were -$1.45 [S2].
• The company received Nasdaq notice in May 2025 for non-compliance with minimum bid price requirement of $1.00, with extended periods to regain compliance through May 1, 2026 [S1].
• The company authorized a one-time payment to stockholders of $0.13 per share in November 2025 [S1].
• Recent news highlights include Q3 2025 loss with revenue exceeding expectations, Q2 2025 profit, securing $27 million financing to support M&A and software growth, partnerships to integrate AI-driven recommendation engines, and consulting agreements for IPO services [N1][N7][N8].